PANC — Panacos Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$8.68m
- $0.18m
Annual cashflow statement for Panacos Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2003 December 27th | R2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.51 | -12 | -59.1 | -38.1 | -37.5 |
| Depreciation | |||||
| Non-Cash Items | 0.059 | 0.719 | 37.2 | 7.77 | 5.02 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.419 | 1.43 | -0.348 | -0.044 | 0.868 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.95 | -9.77 | -21.6 | -29.6 | -31 |
| Capital Expenditures | -0.008 | -0.076 | -0.15 | -0.519 | -0.048 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -0.451 | 0.556 | -25.7 | 15.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.008 | -0.527 | 0.406 | -26.2 | 15.2 |
| Financing Cash Flow Items | — | — | 0 | 0 | -0.332 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.73 | 14.7 | 103 | 1.81 | 20.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.23 | 4.4 | 82.3 | -54 | 4.72 |